Evangelopoulos, D;
McHugh, TD;
(2015)
Improving the Tuberculosis Drug Development Pipeline.
Chemical Biology & Drug Design
, 86
(5)
pp. 951-960.
10.1111/cbdd.12549.
![[thumbnail of EvangelopoulosMcHugh_Improving_the_TB_drug_development_pipeline_Review_Accepted_version.pdf]](https://discovery-pp.ucl.ac.uk/style/images/fileicons/text.png) |
Text
EvangelopoulosMcHugh_Improving_the_TB_drug_development_pipeline_Review_Accepted_version.pdf Download (435kB) |
Abstract
Mycobacterium tuberculosis is considered one of the most successful pathogens and multidrug-resistant tuberculosis, a disease that urgently requires new chemical entities to be developed for treatment. There are currently several new molecules under clinical investigation in the tuberculosis (TB) drug development pipeline. However, the complex lifestyle of M. tuberculosis within the host presents a barrier to the development of new drugs. In this review, we highlight the reasons that make TB drug discovery and development challenging as well as providing solutions, future directions and alternative approaches to new therapeutics for TB.
| Type: | Article |
|---|---|
| Title: | Improving the Tuberculosis Drug Development Pipeline |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/cbdd.12549 |
| Publisher version: | http://dx.doi.org/10.1111/cbdd.12549 |
| Language: | English |
| Additional information: | This is the peer reviewed version of the following article: Evangelopoulos, D; McHugh, TD; (2015) Improving the Tuberculosis Drug Development Pipeline. Chemical Biology & Drug Design, 86 (5) pp. 951-960, which has been published in final form at: http://dx.doi.org/10.1111/cbdd.12549. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html#terms). |
| Keywords: | biological screening, drug development, gene expression, mechanism-based drug design, therapeutic target |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute > Microbial Diseases |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1464395 |
Archive Staff Only
 |
View Item |
